These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 32795564)
1. Risk of Psychiatric Adverse Events Among Montelukast Users. Sansing-Foster V; Haug N; Mosholder A; Cocoros NM; Bradley M; Ma Y; Pennap D; Dee EC; Toh S; Pestine E; Petrone AB; Kim I; Lyons JG; Eworuke E J Allergy Clin Immunol Pract; 2021 Jan; 9(1):385-393.e12. PubMed ID: 32795564 [TBL] [Abstract][Full Text] [Related]
2. Assessing the risk of intentional self-harm in montelukast users: an updated Sentinel System analysis using ICD-10 coding. Apata J; Lyons JG; Bradley MC; Ma Y; Kempner ME; Kim I; Eworuke E; Pennap D; Mosholder A J Asthma; 2024 Jul; 61(7):653-662. PubMed ID: 38064517 [TBL] [Abstract][Full Text] [Related]
3. Risk of neuropsychiatric adverse events associated with montelukast use in children and adolescents: a population-based case-crossover study. Kim JW; Kim M; Seo MS; Shin JY BMJ Paediatr Open; 2024 Sep; 8(1):. PubMed ID: 39251365 [TBL] [Abstract][Full Text] [Related]
4. Analysis of Neuropsychiatric Diagnoses After Montelukast Initiation. Paljarvi T; Forton J; Luciano S; Herttua K; Fazel S JAMA Netw Open; 2022 May; 5(5):e2213643. PubMed ID: 35608857 [TBL] [Abstract][Full Text] [Related]
5. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366 [TBL] [Abstract][Full Text] [Related]
6. Neuropsychiatric events associated with montelukast in patients with asthma: a systematic review. Lo CWH; Pathadka S; Qin SX; Fung LWY; Yan VKC; Yiu HHE; Bloom CI; Wong ICK; Chan EWY Eur Respir Rev; 2023 Sep; 32(169):. PubMed ID: 37758273 [TBL] [Abstract][Full Text] [Related]
8. Relationship between montelukast and behavioral problems in preschool children with asthma. Özata E; Akelma Z; Günbey S Allergol Immunopathol (Madr); 2022; 50(1):85-91. PubMed ID: 34965642 [TBL] [Abstract][Full Text] [Related]
9. Exploring the possible association between montelukast and neuropsychiatric events among children with asthma: a matched nested case-control study. Ali MM; O'Brien CE; Cleves MA; Martin BC Pharmacoepidemiol Drug Saf; 2015 Apr; 24(4):435-45. PubMed ID: 25683909 [TBL] [Abstract][Full Text] [Related]
10. The Risk of Neuropsychiatric Adverse Events With Use of Leukotriene Receptor Antagonists in Patients With Asthma: Analysis of Korea's National Health Insurance Sharing Service Database. Kim JH; Lee H; Jeong D; Lee JH; Kwon HS; Song WJ; Cho YS; Kim YJ; Shin YW; Kim TB J Allergy Clin Immunol Pract; 2023 Dec; 11(12):3690-3699.e7. PubMed ID: 37660732 [TBL] [Abstract][Full Text] [Related]
11. Neuropsychiatric adverse drug reactions in children initiated on montelukast in real-life practice. Benard B; Bastien V; Vinet B; Yang R; Krajinovic M; Ducharme FM Eur Respir J; 2017 Aug; 50(2):. PubMed ID: 28818882 [TBL] [Abstract][Full Text] [Related]
12. Montelukast for prevention and treatment of asthma exacerbations in adults: Systematic review and meta-analysis. Zhang HP; Jia CE; Lv Y; Gibson PG; Wang G Allergy Asthma Proc; 2014; 35(4):278-87. PubMed ID: 24992547 [TBL] [Abstract][Full Text] [Related]
14. The role of inhaled corticosteroids and montelukast in children with mild-moderate asthma: results of a systematic review with meta-analysis. Castro-Rodriguez JA; Rodrigo GJ Arch Dis Child; 2010 May; 95(5):365-70. PubMed ID: 19946008 [TBL] [Abstract][Full Text] [Related]
15. Roflumilast combined with montelukast versus montelukast alone as add-on treatment in patients with moderate-to-severe asthma. Bateman ED; Goehring UM; Richard F; Watz H J Allergy Clin Immunol; 2016 Jul; 138(1):142-149.e8. PubMed ID: 26915674 [TBL] [Abstract][Full Text] [Related]
16. Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma. Wechsler ME; Finn D; Gunawardena D; Westlake R; Barker A; Haranath SP; Pauwels RA; Kips JC; Drazen JM Chest; 2000 Mar; 117(3):708-13. PubMed ID: 10712995 [TBL] [Abstract][Full Text] [Related]
17. FDA warning montelukast 03.2020-Statement of the Austrian working group of pediatric pulmonology and allergology. Zschocke A; Horak F; Eber E; Frischer T; Simma B; Stetzl W; Riedler J; Szépfalusi Z; Zacharasiewicz A Wien Klin Wochenschr; 2022 Jan; 134(1-2):86-88. PubMed ID: 34904177 [TBL] [Abstract][Full Text] [Related]
18. Montelukast: a review of its therapeutic potential in persistent asthma. Jarvis B; Markham A Drugs; 2000 Apr; 59(4):891-928. PubMed ID: 10804041 [TBL] [Abstract][Full Text] [Related]
19. Lower Limb Bruising Associated with Montelukast in an Asthmatic Child. Trayer J; Nadeem M; Elnazir B J Paediatr Child Health; 2021 Aug; 57(8):1343. PubMed ID: 34009696 [No Abstract] [Full Text] [Related]
20. Montelukast and emotional well-being as a marker for depression: results from 3 randomized, double-masked clinical trials. Holbrook JT; Harik-Khan R J Allergy Clin Immunol; 2008 Oct; 122(4):828-829. PubMed ID: 18760460 [No Abstract] [Full Text] [Related] [Next] [New Search]